{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:49:57Z","timestamp":1791348597243,"version":"4.3.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.xphs.2026.104513","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:14:58Z","timestamp":1790205298000},"page":"104513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation of the effect of formulated sodium lauryl sulfate on microenvironment-driven dissolution of repotrectinib immediate-release capsules"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1061-6899","authenticated-orcid":false,"given":"Zongyun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.xphs.2026.104513_bib0001","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/2159-8290.CD-18-0484","article-title":"Repotrectinib (TPX-0005) is a next-generation ROS1\/TRK\/ALK inhibitor that potently inhibits ROS1\/TRK\/ALK solvent- front mutations","volume":"8","author":"Drilon","year":"2018","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.xphs.2026.104513_bib0002","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1158\/1535-7163.MCT-21-0632","article-title":"Molecular characteristics of repotrectinib that enable potent inhibition of TRK fusion proteins and resistant mutations","volume":"20","author":"Murray","year":"2021","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1016\/j.xphs.2026.104513_bib0003","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/cpdd.299","article-title":"Effect of the wetting agent sodium lauryl sulfate on the pharmacokinetics of alectinib: results from a bioequivalence study in healthy subjects","volume":"6","author":"Holzem","year":"2017","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"10","key":"10.1016\/j.xphs.2026.104513_bib0004","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1016\/j.xphs.2024.07.017","article-title":"Oral absorption from surfactant-based drug formulations: the impact of molecularly dissolved drug on bioavailability","volume":"113","author":"Holzem","year":"2024","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.xphs.2026.104513_bib0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jsps.2022.02.006","article-title":"The role of sodium lauryl sulfate on formulation of directly compressed tablets containing simvastatin and aspirin: effect on drugs dissolution and gastric mucosa","volume":"30","author":"Alshora","year":"2022","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.xphs.2026.104513_bib0006","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.cherd.2023.04.011","article-title":"A high throughput approach of selecting excipients for solubility enhancement of BCS Class II active pharma","volume":"193","author":"Bahr","year":"2023","journal-title":"Chem. Eng. Res. Des."},{"key":"10.1016\/j.xphs.2026.104513_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123265","article-title":"Sodium lauryl sulfate as lubricant in tablets formulations: is it worth?","volume":"643","author":"Sabbatini","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.xphs.2026.104513_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121310","article-title":"Formulation strategies for mitigating dissolution reduction of p-aminobenzoic acid by sodium lauryl sulfate through diffusion layer modulation","volume":"611","author":"Guo","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.xphs.2026.104513_bib0009","unstructured":"US Food and Drug Administration. 1997. Guidance for industry, dissolution testing of immediate release solid oral dosage forms."},{"key":"10.1016\/j.xphs.2026.104513_bib0010","unstructured":"United States Pharmacopeial Convention: Sodium Lauryl Sulfate, in: USP\u2013NF, United States pharmacopeial convention, Rockville, MD, 2021, monograph M76790, 10.31003\/USPNF_M76790_06_01."},{"key":"10.1016\/j.xphs.2026.104513_bib0011","series-title":"European Pharmacopoeia","year":"2023"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:53:40Z","timestamp":1791345220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0022354926003631"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104513","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the effect of formulated sodium lauryl sulfate on microenvironment-driven dissolution of repotrectinib immediate-release capsules","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104513"}}